About Breast Cancer Breast Cancer is the most common cancer among women other than skin cancer. It affects millions of women around the world, and each year nearly 200,000 women get newly diagnosed. Breast Cancer is cancer that first forms within the breast. But it can grow into surrounding areas and, in later stages, spread throughout the body if left untreated.
 
Research has shown that if all women age 50 and older would have a mammogram each year, it would reduce Breast Cancer deaths by 30%. Certain risk factors may put you at a higher risk. These include getting older, a history of previous breast cancer, late childbearing, and other factors. Doing monthly self-exams of your breasts is the best way to find early warning signs. A mass or lump in the breast or underarm, changes in size, shape, color or texture of the breast, and blood or fluid leaking from the nipple are all warning signs of possible Breast Cancer.
 
Would you like more information about the warning signs of Breast Cancer, or Breast Cancer screening and diagnosis? Download the free "A Patient's Guide to Understanding Breast Cancer" brochure. And be sure to visit our Resources section for links to Breast Cancer Resources.
 

XELODA and Breast Cancer

XELODA is used to treat breast cancer that has spread to other parts of the body, which is called metastatic Breast Cancer. To treat this type of cancer, XELODA can be taken together with another medicine called Taxotere®1 (docetaxel). It has also been approved to be used alone ("monotherapy") to treat this type of breast cancer in certain patients. Sometimes Breast Cancer that spreads to other parts of the body is treated with other medicines. These medicines include paclitaxel and anthracycline-containing medicines such as Adriamycin®2 (doxorubicin). If the patient's Breast Cancer has not improved after treatment with other medicines, XELODA may be taken alone to treat it.
 
In this section of XELODA.com, you can find out more about Breast Cancer and how it is diagnosed. You can also learn about diagnostic tests and the types of treatments available, such as surgery, chemotherapy, and radiation treatment. For the latest information about Breast Cancer, browse the Web sites listed in our Breast Cancer links.
 
FOOTNOTE
1. Taxotere® (docetaxel) is a registered trademark of Aventis Pharmaceuticals Inc.
2. Adriamycin® is a registered trademark of Pharmacia.
Roche Laboratories Inc. THIS SITE INTENDED FOR U.S. AUDIENCES ONLY
Copyright © 2004-2008 Roche Laboratories Inc. All rights reserved.
Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement.
 
For more information about XELODA, contact your physician or other healthcare professional.